Jaguar Health, Inc. (JAGX)
Nasdaq: JAGX · Pharmaceutical Preparations · San Francisco, CA · filing with the SEC since 2013
Filings
792 filings since 2017 beside 165 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 50 days after the quarter ended. The proxy statement was last filed Oct 8, 2026.
Filings a yearinsider forms included
1301277676595810787
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest May 4, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Feb 20, 2025.SEC letters: 10 in the last 36 months, the newest Nov 24, 2025.A late-filing notice, Form NT 10-Q, filed Aug 14, 2026.A late-filing notice, Form NT 10-Q, filed May 18, 2026.A late-filing notice, Form NT 10-K, filed Apr 1, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 6, 2026
8-K items 5.07, 7.01, 9.01
Shareholder vote; Investor disclosure (Regulation FD) · Current report
Oct 5, 2026
8-K items 1.01, 2.03, 3.03, 5.03, 7.01, 8.01, 9.01
Major agreement signed; New debt or obligation taken on; Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD); Other event · Current report
Sep 30, 2026
Sep 28, 2026
8-K items 1.01, 3.02, 8.01, 9.01
Major agreement signed; Shares sold without registration; Other event · Current report
Sep 25, 2026
Sep 25, 2026
8-K items 1.01, 1.02, 3.02, 8.01, 9.01
Major agreement signed; Major agreement ended; Shares sold without registration; Other event · Current report
Sep 23, 2026
Sep 24, 2026
8-K items 1.01, 3.02, 8.01, 9.01
Major agreement signed; Shares sold without registration; Other event · Current report
Sep 23, 2026
Sep 21, 2026
8-K items 3.03, 5.03, 8.01, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change; Other event · Current report
Sep 15, 2026
Sep 15, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Sep 11, 2026
Sep 15, 2026
8-K items 3.03, 5.03, 7.01, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Sep 14, 2026
40 of 792 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.